Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/524632 stock hub

BOM/524632 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BOM/524632is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
14.7B
Bombay Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BOM/524632
In the news

Latest news · BOM/524632

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E67.1
P25 n/aP50 n/aP75 n/a
ROE28.9
P25 n/aP50 n/aP75 n/a
ROIC31.6
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BOM/524632 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
218
Groups with data
11
Currency
INR
Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
India
Country code
IN
Employees
115
Employees Change
-67%
Employees Change Percent
-36.81
Enterprise value
INR 14.7B
Exchange
Bombay Stock Exchange
Financial currency
INR
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
INR 14.7B
Price
INR 33.54
Price currency
INR
Rev Per Employee
5,331,495.65x
Sic
2834
Symbol
bom/524632
Website
https://www.shukrapharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
1.5%
EV Earnings
66.54x
EV/EBIT
49.12x
EV/EBITDA
44.04x
EV/FCF
-124.39x
EV/Sales
23.94x
FCF yield
-0.8%
P/B ratio
16.35x
P/E ratio
67.08x
P/S ratio
23.95x
PE Ratio10 Y
90.02x
PE Ratio3 Y
54.49x
PE Ratio5 Y
134.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
48.73%
EBITDA Margin
54.35%
Gross margin
74.15%
Gross Profit
INR 454.6M
Gross Profit Growth
87.13%
Gross Profit Growth Q
-84.5%
Gross Profit Growth3 Y
47.85%
Gross Profit Growth5 Y
40.09%
Net Income
INR 220.6M
Net Income Growth
130.37%
Net Income Growth3 Y
71.06%
Net Income Growth5 Y
159.32%
Pretax Margin
46.95%
Profit Margin
35.98%
Profit Per Employee
INR 1.9M
ROA
18.29
Roa5y
10.27
ROCE
31.67
ROE
28.89
Roe5y
23.07
ROIC
31.56
Roic5y
24.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr10y
60.05%
Cagr1y
157.46%
Cagr3y
126.84%
Cagr5y
134.9%
Div CAGR3
-7.17%
Div CAGR5
-4.36%
EPS Growth
128.7
EPS Growth3 Y
-8.61
EPS Growth5 Y
75.5
OCF Growth
-50.35%
OCF Growth10 Y
3.76%
OCF Growth3 Y
7.44%
OCF Growth5 Y
48.89%
Revenue Growth
88.15x
Revenue Growth Q
-30.94x
Revenue Growth3 Y
1.01x
Revenue Growth5 Y
40.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
INR 0.6
Assets
INR 1.2B
Cash
INR 59.8M
Current Assets
INR 838.1M
Current Liabilities
INR 230.9M
Debt
INR 50.2M
Debt EBITDA
INR 0.15
Debt Equity
INR 0.06
Debt FCF
INR -0.43
Equity
INR 898.5M
Interest Coverage
27.34
Liabilities
INR 275.9M
Long Term Assets
INR 336.3M
Long Term Liabilities
INR 45M
Net Cash
INR 9.6M
Net Cash By Market Cap
INR 0.07
Net Cash Growth
-87.95%
Net Debt EBITDA
INR -0.03
Net Debt Equity
INR -0.01
Tangible Book Value
INR 898.5M
Tangible Book Value Per Share
INR 2.09
WACC
7.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.63
Inventory Turnover
1.33
Net Working Capital
INR 565.7M
Quick ratio
1.25
Working Capital
INR 607.2M
Working Capital Turnover
INR 1.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.75%
Dividend Growth
-90%
Dividend Growth Years
0%
Dividend per share
INR 0.01
Dividend Years
4
Dividend Yield
0.03%
Ex Div Date
2025-09-18
Last Dividend
INR 0.01
Payout Frequency
Annual
Payout Ratio
1.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
10,923.43%
1Y total return
157.29%
200-day SMA
36.82
3Y total return
1,067.94%
50-day SMA
35.73
50-day SMA vs 200-day SMA
50under200
5Y total return
7,047.87%
All Time High
65.26
All Time High Change
-48.61%
All Time High Date
2025-12-19
All Time Low
0.29
All Time Low Change
11,465.52%
All Time Low Date
2020-11-09
ATR
1.99
Beta
0.55
Beta1y
0.39
Beta2y
-0.11
Ch YTD
-43.39
High
34.9
High52
65.26
High52 Date
2025-12-19
High52ch
-48.61%
Low
33.54
Low52
11.74
Low52 Date
2025-05-12
Low52ch
185.69%
Ma50ch
-6.13%
Price vs 200-day SMA
-8.9%
RSI
50.2
RSI Monthly
56.41
RSI Weekly
44.42
Sharpe ratio
1.67x
Sortino ratio
2.63
Total Return
-0.72%
Tr YTD
-43.39
Tr1m
-3.12%
Tr1w
9.97%
Tr3m
-20.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
INR 298.8M
Operating Income Growth
140
Operating Income Growth Q
-89.94
Operating Income Growth3 Y
85.8
Operating Income Growth5 Y
154.5
Operating margin
48.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
46,743,840%
Net Borrowing
800,000
Shares Insiders
41.59%
Shares Out
437,879,440
Shares Qo Q
-0.98%
Shares Yo Y
0.75%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
INR -118M
Average Volume
510,386.5x
Bv Per Share
2.09
CAPEX
INR -157.3M
Ch10y
2,072.3
Ch1m
-3.12
Ch1w
9.97
Ch1y
157.2
Ch3m
-20.99
Ch3y
1,045.9
Ch5y
1,355.7
Ch6m
-18.14
Change
-4.99%
Change From Open
0
Close
35.3
Days Gap
-4.99
Depreciation Amortization
34,427,000
Dollar Volume
38,647,068.7
Earnings Date
2026-05-07
EBIT
INR 298.8M
EBITDA
INR 333.2M
EPS
INR 0.5
F Score
4
FCF
INR -118M
FCF EV Yield
-0.8x
FCF Per Share
INR -0.27
Financing CF
40,703,000
Fiscal Year End
March
Founded
1,993
Graham Number
4.85377
Graham Upside
-85.53
Income Tax
INR 67.3M
Investing CF
-141,431,000
Is Primary Listing
1
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Date
2025-03-21
Last Split Type
Forward
Lynch Fair Value
INR 12.5
Lynch Upside
-62.73
Ma150
41.07
Ma150ch
-18.34%
Ma20
32.71
Ma20ch
2.55%
Net CF
-61,414,000
Next Earnings Date
2026-05-26
Open
33.54
P OCF Ratio
373.6
Payment Date
2025-10-30
Position In Range
0
Ppne
336,301,000
Price Date
2026-05-08
Price EBITDA
INR 44.07
Ptbv Ratio
16.35
Relative Volume
2.26x
Revenue
613,122,000x
Tax By Revenue
10.97x
Tax Rate
23.37%
Tr6m
-18.14%
Volume
1,152,268
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

BOM/524632 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.0%
$0.01 annual per share
Payout ratio
+2.0%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-4.4%
0 consecutive years of growth
Total shareholder yield
-0.7%
Next ex-dividend date: 2025-09-18
Performance

BOM/524632 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+157.3%
S&P 500 1Y: n/a
3Y total return
+1067.9%
S&P 500 3Y: n/a
5Y total return
+7047.9%
S&P 500 5Y: n/a
10Y total return
+10923.4%
S&P 500 10Y: n/a
Ownership

Who owns BOM/524632?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+41.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.8%
Negative means the company is buying back shares.
Technical

BOM/524632 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
50.2
Neutral momentum band
Price vs 200-day MA
-8.9%
50/200-day relationship not available
Beta (5Y)
0.55
Less volatile than the market
Sharpe ratio
1.67
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BOM/524632

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/524632 stock rating?

bom/524632 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/524632 analysis?

The full report lives at /stocks/bom/524632/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/524632?

The latest report frames bom/524632 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/524632 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bom/524632 stock profile: metrics, valuation and analysis | Agente de Mercado de Ações com IA